Skip to content
10-Q

Quarterly Report

KEDEM PHARMACEUTICALS INC.

0001493152-12-001429

← back to feed
Filed
Oct 15, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Oct 15, 2012 21.59M sh
Operating Cash Flow Q1 2013 · Aug 31, 2012 −$148.27K
Operating Cash Flow Q1 2013 · Aug 31, 2012 −$4.7M
Operating Cash Flow Q1 2013 · Aug 31, 2011 −$635.75K
Cash And Equivalents Q1 2013 · Aug 31, 2012 $236.78K
Cash And Equivalents Q1 2013 · May 31, 2012 $294.94K
Cash And Equivalents Q1 2013 · Aug 31, 2011 $1.39M
Cash And Equivalents Q1 2013 · May 31, 2011 $1.49M
Stockholders Equity Q1 2013 · Aug 31, 2012 −$4.06M
Stockholders Equity Q1 2013 · May 31, 2012 −$3.28M
Stockholders Equity Q1 2013 · May 31, 2011 $584.69K
Stockholders Equity Q1 2013 · May 31, 2009 $281.74K
Stockholders Equity Q1 2013 · May 31, 2008 −$92.88K
Current Liabilities Q1 2013 · Aug 31, 2012 $4.86M
Current Liabilities Q1 2013 · May 31, 2012 $4.4M
Current Assets Q1 2013 · Aug 31, 2012 $356.49K
Current Assets Q1 2013 · May 31, 2012 $416.67K
Total Assets Q1 2013 · Aug 31, 2012 $796.76K
Total Assets Q1 2013 · May 31, 2012 $1.12M
Sga Expense Q1 2013 · Aug 31, 2012 $52.75K
Sga Expense Q1 2013 · Aug 31, 2012 $1.01M
Sga Expense Q1 2013 · Aug 31, 2011 $125.99K
Rd Expense Q1 2013 · Aug 31, 2012 $116.93K
Rd Expense Q1 2013 · Aug 31, 2012 $2.14M
Rd Expense Q1 2013 · Aug 31, 2011 $354.26K
Net Income Q1 2013 · Aug 31, 2012 −$751.05K
Net Income Q1 2013 · Aug 31, 2012 −$13.12M
Net Income Q1 2013 · May 31, 2012 −$5.91M
Net Income Q1 2013 · Aug 31, 2011 −$1.61M
Net Income Q1 2013 · May 31, 2011 −$4.17M
Net Income Q1 2013 · May 31, 2010 −$2.18M
Net Income Q1 2013 · May 31, 2009 −$173.26K
Operating Income Q1 2013 · Aug 31, 2012 −$413.66K
Operating Income Q1 2013 · Aug 31, 2012 −$6.92M
Operating Income Q1 2013 · Aug 31, 2011 −$725.23K